甲状腺嗜酸细胞癌:来自20年患者队列的结论
该研究回顾性分析2000至2021年一家三级医院51例甲状腺嗜酸细胞癌(OCA)患者,平均诊断年龄60.3岁,90%以可触及肿块就诊,24%有甲状腺癌家族史;组织学显示63%有血管侵犯、35%有淋巴血管侵犯、15%有甲状腺外侵犯;77%接受放射性碘辅助治疗;作者认为OCA具有区别于其他分化型甲状腺癌的独特特征,需进一步聚焦研究以明确其侵袭性、治疗选择与预后。
要点
- 51例OCA患者中90%以可触及肿块就诊,24%有甲状腺癌家族史。
- 组织学上63%有血管侵犯、35%有淋巴血管侵犯、15%有甲状腺外侵犯。
- 77%接受放射性碘辅助治疗,作者认为需进一步聚焦研究明确其侵袭性、治疗与预后。
核心结论
- OCA具有区别于其他分化型甲状腺癌的独特特征,需进一步聚焦研究以明确其侵袭性、治疗选择与预后。
研究设计与样本
- 回顾性分析2000至2021年一家三级医院收治的51例甲状腺嗜酸细胞癌(OCA)患者(22例男性、29例女性)。
主要发现
- 平均诊断年龄60.3岁,90%以可触及肿块就诊,24%有甲状腺癌家族史,均无声带麻痹。
- 超声显示多数肿瘤为实性、低回声;14例细针穿刺(FNA)中93%为Bethesda-4类病变。
- 全部患者接受手术治疗;组织学上63%有血管侵犯、35%有淋巴血管侵犯、15%有甲状腺外侵犯。
- 77%接受放射性碘辅助治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oncocytic carcinoma (OCA) was recently reclassified as a distinct differentiated thyroid carcinoma (DTC). Given its rarity, OCA studies are limited. This study describes the characteristics of OCA in a 20-year cohort. METHODS: Retrospective analysis of patients with OCA at a single tertiary care hospital from 2000 to 2021. RESULTS: Fifty-one OCA patients (22M:29F) were identified. The mean age at diagnosis was 60.3 years; 90% presented as palpable mass; 24% had a family history of thyroid cancer. None had vocal fold paresis. On ultrasound, most tumors were solid and hypoechoic. FNA (n = 14) showed Bethesda-4 lesions in 93%. All were treated surgically. Histologically, 63% demonstrated angioinvasion, 35% had lymphovascular invasion, and 15% had extrathyroidal extension. Radioactive iodine was used as adjunct therapy in 77%. CONCLUSION: OCA has distinct features that distinguish it from other DTCs, and additional focused studies will help clarify the aggressive nature, treatment options, and prognosis of the disease.
引用
- Gruszczynski NR, Hasan SS, Brennan AG, et al. Oncocytic carcinoma of the thyroid: Conclusions from a 20-year patient cohort. Head Neck. 2024. PMID: 38390640. doi:10.1002/hed.27700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。